(MedPage Today) — Americans’ use of GLP-1 injectables for weight loss reached a record high, nearly quadrupling since 2024, according to a national Gallup poll.
For patients with type 2 diabetes and peripheral artery disease, GLP-1 receptor agonists…
Source link : https://www.medpagetoday.com/endocrinology/generalendocrinology/122086
Author :
Publish date : 2026-07-07 19:45:00
Copyright for syndicated content belongs to the linked Source.
